ArticleAIDS (London, England)2016

Benefits of continuous isoniazid preventive therapy may outweigh resistance risks in a declining tuberculosis/HIV coepidemic.

Amber Kunkel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.